November 14, 2025 Release Highlights Copied
Practice Insights is pleased to announce updates in the application to support the Merit-Based Incentive Payment System (MIPS) and Enhancing Oncology Model (EOM).
MIPS Quality Measures Dashboard
The MIPS Quality Measures Dashboard will be updated to reflect the following refinement(s):
| Measure | Update | Practice Impact |
| PIMSH 18: Resolution or Improvement of a Health-Related Social Need | Technical enhancement now pulls data from the Observation Date and not the Updated Date to ensure credit is attributing appropriately for reported resolution or improvement within the Numerator population.
Denominator attribution update for all providers with two qualifying encounters with a positive screening for one or more of the 5 domains of HRSN screening. Numerator attribution update for all providers with a reported resolution of at least 1 health-related social need or improvement to distress score within 6 months. Technical fix to ensure the denominator identification period of July 1 of the previous performance period through June 30 of the current performance period is captured and correctly attributed. Added in telehealth modifier 95 code. |
Practices will notice a shift in the Denominator and Numerator. |
| Promoting Interoperability: Provide Patients Electronic Access to Their Health Information | Technical fix to ensure patients are attributed when a patient is provided access to view online, download, and transmit their health information. Previously, there was a technical defect where credit was not provided when clinicians provided the patient’s health information to the patient. | Practices should not see an impact to the Denominator. Some practices will see an increase in the Numerator. |
| Preventive Care Screening:
Screening for Depression and Follow-Up Plan MIPS 134 eCQM MIPS 134 Registry/CQM EOM-5 |
Technical fix to ensure follow-up plans documented within the 2-day window timeframe are properly attributed to Numerator credit. Previously, credit was not attributed if the follow-up plan was not documented on the same day as the qualifying visit.
Technical fix to ensure Numerator credit is attributed properly across patients with multiple visits on the same day: Numerator met encounters will receive precedence over a patient declining to participate in the assessment when the patient has multiple encounters on the same day. Technical fix to ensure the most recent encounter receives Numerator credit when a patient has multiple visits within the measurement period on different days. Technical fix to ensure patients with bipolar disorder diagnosis are appropriately attributed as Denominator Exclusions. MIPS 134 Registry/CQM & EOM‑5: Added in telehealth modifier 95 code. |
Practices will notice a shift in the Denominator and Numerator. |
Status of Dashboard Updates for 2025
CMS releases updates to the quality measure specifications annually for the MIPS program. These measure specifications have been reviewed, and Practice Insights is working on the required technical updates to align with the revised requirements. Ontada will continue to notify practices once measures have been updated based on the current 2025 requirements.
| Measure Number | Description |
| MIPS Quality Measures Dashboard | |
| MIPS #001 | Diabetes Hemoglobin A1c (HbA1cc) Poor Control (>9%) (Inverse Measure) |
| MIPS #047 | Advance Care Plan |
| MIPS #130 | Current Medications Documentation |
| MIPS #134 eCQM | Preventive Care Screening: Screening for Depression and Follow Up Plan |
| MIPS #134 CQM/Registry | Preventive Care Screening: Screening for Depression and Follow Up Plan |
| MIPS #143 | Pain Intensity Quantified |
| MIPS #144 | Pain Care Plan |
| MIPS #226 | Tobacco Screening and Cessation |
| MIPS #236 | Controlling High Blood Pressure |
| MIPS #238 | Use of High-Risk Medications in Older Adults (Inverse Measure) |
| MIPS #374 | Closing the Referral Loop |
| MIPS #450 | Appropriate Treatment for Patients with Stage I (T1c) III Her2 Positive Breast Cancer |
| MIPS #451 | RAS (KRAS & NRAS) Testing Performed for Patients with Metastatic Colorectal Cancer who Receive Anti-EGFR Monoclonal Antibody Therapy |
| MIPS #453 | Proportion Receiving Chemotherapy in the Last 14 Days of Life (Inverse Measure) |
| MIPS #457 | Percentage of Patients who Died from Cancer Admitted to Hospice for Less than 3 Days |
| MIPS #462 | Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy |
| MIPS #487 | Screening for Social Drivers of Health |
| PIMSH #1 | Advance Care Planning in Metastatic Disease |
| PIMSH #4 | Patient-Reported Pain Improvement |
| PIMSH #9 | Supportive Care Drug Utilization in the Last 14 Days of Life (Inverse Measure) |
| PIMSH #10 | Hepatitis B Serology Testing and Prophylactic Treatment Prior to Receiving Anti-CD20 Targeting Drugs |
| PIMSH #13 | Proportion of Stage IV nsNSCLC Patients Tested for Actionable Biomarkers and Received Mutation-Targeted Therapy |
| PIMSH #15 | Antiemetic Therapy for Low-and Minimal-Emetic-Risk Antineoplastic Agents in the Infusion Center-Avoidance of Overuse (Inverse Measure) |
| PIMSH #16 | Appropriate Antiemetic Therapy for High-and Moderate-Emetic-Risk Antineoplastic Agents in the Infusion Center |
| PIMSH #17 | Utilization of Prophylactic GCSF for Cancer Patients Receiving Low-Risk Chemotherapy (Inverse Measure) |
| PIMSH #18 | Resolution or Improvement of a Health-Related Social Need |
| EOM Performance Measures Dashboard | |
| EOM-4A | Pain Intensity Quantified |
| EOM-4B | Pain Care Plan |
| EOM-5 | Preventive Care Screening: Screening for Depression and Follow Up Plan |